U.S. Electronic Equipment and Components Stock News

NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

What BridgeBio Pharma (BBIO)'s Surging 2025 Revenue and Growing Losses Means For Shareholders

BridgeBio Pharma, Inc. has reported its fourth-quarter and full-year 2025 results, with Q4 revenue rising to US$154.18 million from US$5.88 million a year earlier and full-year 2025 revenue reaching US$502.08 million, while the company’s annual net loss increased to US$724.93 million and basic loss per share from continuing operations was US$3.78. Management framed these results as a turning point, highlighting accelerating commercial traction for ATTR-CM drug Attruby and multiple positive...
NYSE:LOW
NYSE:LOWSpecialty Retail

How 2026 Sales and Margin Guidance At Lowe's (LOW) Has Changed Its Investment Story

Lowe’s Companies has already reported fourth-quarter and full-year 2025 results, with sales rising to US$20,584 million for the quarter and US$86,286 million for the year, while net income and earnings per share eased compared with the prior year. The company also issued 2026 guidance calling for total sales of US$92.00 billion to US$94.00 billion, operating margins above 11%, and EPS of about US$11.75 to US$12.25, underpinned by recent acquisitions that are expected to materially lift...
NYSE:NSA
NYSE:NSASpecialized REITs

National Storage Affiliates Trust Sharpens Platform With Q4 Progress And Portfolio Moves

National Storage Affiliates Trust (NYSE:NSA) reported solid Q4 operational progress, including better occupancy metrics and revenue trends across most markets. The company completed the consolidation of another brand, aiming to simplify its platform and improve operational consistency. NSA continued to refine its portfolio through asset sales, new acquisitions and joint ventures, while keeping liquidity conditions supportive of these moves. For investors tracking NYSE:NSA, the recent...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Churchill Downs (CHDN) Margin Decline Tests Bullish Growth Narratives After FY 2025 Results

Churchill Downs (CHDN) has wrapped up FY 2025 with fourth quarter revenue of US$665.9 million and basic EPS of US$0.71, alongside trailing twelve month revenue of US$2.9 billion and EPS of US$5.36. The company has seen quarterly revenue move from US$624.2 million in Q4 2024 to US$665.9 million in Q4 2025, while basic EPS shifted from US$0.99 to US$0.71 over the same period. This sets up a contrast with a trailing net margin of 13.1% versus 15.6% a year earlier, which keeps investor attention...
NYSE:SILA
NYSE:SILAHealth Care REITs

A Look At Sila Realty Trust (SILA) Valuation After Earnings, Acquisitions, Dividend Affirmation And Index Additions

Sila Realty Trust (SILA) caught investor attention after a fresh earnings release and a reaffirmed quarterly dividend, combining updated financials with a continued cash payout that speaks directly to income focused shareholders. See our latest analysis for Sila Realty Trust. The fresh earnings release, dividend affirmation and earlier index inclusions come against a share price of US$26.03, with a 30 day share price return of 6.33% and year to date share price return of 10.77%, suggesting...
NYSE:USAC
NYSE:USACEnergy Services

USA Compression Partners Targets Growth In Cleaner Fuels And LNG Exports

USA Compression Partners (NYSE:USAC) plans to add substantial new compression equipment by year end. The move comes as many energy service providers report softer equipment demand and cautious upstream spending. The partnership is targeting projects tied to cleaner fuels and growing US LNG exports. For investors watching energy infrastructure, USA Compression Partners stands out for leaning into new equipment investments while much of the sector remains cautious. The units trade around...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Applied Materials Highlights Supplier Awards As AI Demand And Valuation Scrutinized

Applied Materials has honored 12 suppliers with its Supplier Excellence Awards. The awards highlight key partners that support Applied Materials' materials engineering systems for advanced chips. The company is underscoring quality, service, and sustainability across its supply chain as AI computing drives higher semiconductor demand. For investors watching NasdaqGS:AMAT, this supplier recognition comes as the stock trades around $375.72, with a return of 39.7% year to date and 142.0% over...
NasdaqGS:JJSF
NasdaqGS:JJSFFood

Is It Time To Revisit J&J Snack Foods (JJSF) After Its 1-Year Share Price Slump?

If you are wondering whether J&J Snack Foods is starting to look attractively priced, you are not alone. This article will help you make sense of where the stock stands today. The shares last closed at US$85.11, with returns of 0.0% over 7 days, a 9.7% decline over 30 days, a 6.0% decline year to date, and a 33.6% decline over 1 year that sits against a 36.5% decline over 3 years and a 39.4% decline over 5 years. These moves have kept J&J Snack Foods on the radar for investors looking at...
NYSE:MSA
NYSE:MSACommercial Services

A Look At MSA Safety (MSA) Valuation After Recent Share Price Momentum

MSA Safety stock snapshot after recent performance shift MSA Safety (MSA) is drawing attention after a recent stretch where the share price shows a 0.2% move over one day, a 1% decline over the week, and positive returns over the month and past 3 months. See our latest analysis for MSA Safety. At a share price of $196.02, MSA Safety’s recent 8.8% 1 month share price return and 21.5% 3 month share price return sit alongside a 1 year total shareholder return of 22.5% and 3 year total...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Acadia Pharmaceuticals (ACAD) Margin Expansion To 36.5% Tests Bearish Earnings Narratives

ACADIA Pharmaceuticals (ACAD) capped FY 2025 with Q4 revenue of US$284 million and basic EPS of US$1.62, while trailing 12 month revenue reached about US$1.1 billion and basic EPS came in at US$2.32 as the company reported net profit margins of 36.5% over the last year, up from 23.6% the prior year. Over the past year, ACADIA has seen earnings grow 72.7% with a 5 year average earnings growth rate of 66.5% per year, and analysts currently expect earnings to grow about 8.2% per year alongside...
NYSE:NU
NYSE:NUBanks

Nu Holdings (NU) Margin Strength With 41% Net Income Challenges Valuation Skepticism

Nu Holdings (NYSE:NU) has capped FY 2025 with fourth quarter revenue of US$2.1b and basic EPS of US$0.18, while trailing twelve month revenue sits at US$7.0b with EPS of US$0.59, underscoring a period where earnings grew 45.5% over the past year and are forecast to grow about 26.4% per year over the next three years. Over recent periods, the company has seen revenue move from US$5.5b and EPS of US$0.41 on a trailing basis in Q4 2024 to US$7.0b and EPS of US$0.59 by Q4 2025, alongside a...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

Disc Medicine Refocuses On APOLLO Trial After FDA Letter For Bitopertin

Disc Medicine (NasdaqGM:IRON) received a Complete Response Letter from the FDA for its bitopertin candidate for erythropoietic protoporphyria, shifting the drug to a traditional approval pathway. The company now plans to rely on its ongoing APOLLO Phase III trial as the core data package for future regulatory submissions. Management expects APOLLO to reach full enrollment soon, making the trial a key focus for the bitopertin program. For you as an investor, this update centers on how Disc...
NYSE:HHH
NYSE:HHHReal Estate

Howard Hughes Holdings Reshapes Future With Vantage Deal And New Earnings Mix

Howard Hughes Holdings (NYSE:HHH) is moving to acquire Vantage as it reshapes itself into a diversified holding company beyond real estate. The pending deal comes alongside record operational performance from its master planned communities and strong condominium presales. The company is aiming to broaden its revenue and earnings sources outside its traditional property focused model. For investors watching NYSE:HHH, this shift comes after a difficult stretch for the share price, with the...
NYSE:ARDT
NYSE:ARDTHealthcare

Assessing Ardent Health (ARDT) Valuation After New hellocare.ai Virtual Care Partnership

Ardent Health (ARDT) is drawing fresh attention after announcing a partnership with hellocare.ai to roll out an AI assisted virtual care platform across more than 2,000 patient rooms, focused on monitoring and patient safety. See our latest analysis for Ardent Health. The AI partnership sits against a mixed trading backdrop, with a 14.1% 1 month share price return and a 9.7% year to date share price return, while 1 year total shareholder return is a 37.5% decline as legal and accounting...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Is Rigetti Computing (RGTI) Pricing Reflect Its Quantum Roadmap After 120% One-Year Surge

If you are wondering whether Rigetti Computing's recent share price puts it above or below a reasonable value, you are not alone. This article is designed to help you frame that question clearly. Rigetti's stock closed at US$18.64, with a 17.1% return over the past week, a 15.3% decline over the past month, a 21.0% decline year to date, and a 120.3% return over the past year. These moves may leave you questioning whether the current price reflects opportunity or higher risk. Recent news...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Sterling Infrastructure (STRL) Margin Slippage And EPS Softening Test Bullish Growth Narratives

Sterling Infrastructure (STRL) has wrapped up FY 2025 with fourth quarter revenue of US$755.6 million and basic EPS of US$2.85, alongside net income of US$87.6 million, setting a clear marker for how the year finished. Over the past six quarters, the company has seen quarterly revenue move from US$498.8 million in Q4 2024 to US$755.6 million in Q4 2025, while basic EPS shifted from US$3.69 to US$2.85 and trailing twelve month EPS went from US$5.98 in Q3 2024 to US$9.50 in Q4 2025, giving...
NYSE:MNSO
NYSE:MNSOMultiline Retail

Is MINISO Group Holding (MNSO) Pricing Reflect Its Recent Share Price Weakness?

If you are wondering whether MINISO Group Holding is priced attractively or not, this article walks through what the numbers are really saying about its current share price. The stock last closed at US$18.19, with returns over 7 days, 30 days, year to date and 1 year at 7.4% decline, 3.1% decline, 6.7% decline and 9.1% decline, while the 3 year and 5 year returns sit at 6.1% and 27.2% decline respectively. These moves are set against a backdrop of ongoing interest in MINISO's position as a...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Assessing Whether Clover Health Investments (CLOV) Looks Undervalued After Recent Shareholder Return Weakness

Recent performance snapshot for Clover Health Investments (CLOV) Clover Health Investments (CLOV) has seen mixed recent performance, with a 2.9% gain over the past week, contrasted with declines of about 9% over the past month and 13.7% over the past 3 months. See our latest analysis for Clover Health Investments. At a share price of US$2.15, Clover Health Investments has a 1-year total shareholder return decline of 48.1%, while the 3-year total shareholder return is close to a 2x gain,...
NYSE:KNTK
NYSE:KNTKOil and Gas

Kinetik Holdings (KNTK) One Off Driven EPS Surge Tests Bullish Margin Narratives

Kinetik Holdings (KNTK) has just posted its FY 2025 numbers, with Q4 revenue of US$430.4 million and basic EPS of US$2.24, capping a year in which trailing twelve month revenue reached about US$1.8 billion and basic EPS came in at US$2.88. Over the past few reported periods, the company has seen quarterly revenue range from US$426.7 million to US$464.0 million and basic EPS move between roughly US$0.03 and US$2.24. Trailing net profit margins recently sat at 10.1% versus 4.1% a year earlier...
NYSE:MCY
NYSE:MCYInsurance

Mercury General Outlook Stabilizes As Wildfire Risks And Reinsurance Take Focus

AM Best revised Mercury General's (NYSE:MCY) outlook to stable after the January 2025 California wildfire claims. The agency reaffirmed Mercury's financial strength rating, citing an improved balance sheet and risk management. The decision reflects AM Best's view of Mercury's capital position, catastrophe reinsurance program, and claims risk controls. For you as an investor, this rating action speaks directly to how Mercury General is positioned within the personal and commercial insurance...
NYSE:PERF
NYSE:PERFSoftware

Is Perfect (PERF) Quietly Reframing Its Moat Around B2B Beauty Personalization APIs?

Perfect Corp. recently announced a partnership with True Beauty Lashes to power LashLovr™, an AI-driven lash matching and virtual try-on experience that uses its Virtual Try-On and Face Analyzer APIs to help shoppers find better-fitting false lashes in real time. This collaboration highlights how Perfect’s pay-as-you-go AI and AR APIs can lower adoption hurdles for beauty brands while showcasing a concrete, research-backed use case that could support broader B2B uptake of its technology...
NYSE:CC
NYSE:CCChemicals

A Look At Chemours (CC) Valuation As New AI Cooling Partnership And Analyst Updates Refocus Investor Attention

Chemours (CC) has drawn fresh attention after signing a joint development agreement with 2CRSi to advance two phase immersion cooling for data centers and AI infrastructure, alongside a wave of updated analyst views. See our latest analysis for Chemours. The latest 1 day share price return of negative 3.9% and 7 day slide of 15.1% sit against a 90 day share price gain of 35.4% and 1 year total shareholder return of 18.9%. This suggests momentum has cooled recently after a stronger run. If...
NasdaqGS:ADSK
NasdaqGS:ADSKSoftware

Assessing Autodesk (ADSK) Valuation After Recent Share Price Weakness

What Autodesk’s Recent Returns Signal for Investors Autodesk (ADSK) has caught investor attention after a mixed stretch in its share performance, with a small gain over the past week alongside weaker returns over the past month and past 3 months. That backdrop is prompting many investors to revisit the company’s fundamentals, including its recent revenue, profitability, and current valuation metrics, to understand how today’s price compares with Autodesk’s underlying business profile. See our...
NasdaqGS:IBOC
NasdaqGS:IBOCBanks

Assessing International Bancshares (IBOC) Valuation After Earnings Beat And Higher Net Income

International Bancshares (IBOC) just released full year 2025 and fourth quarter results, with net income and earnings per share above the prior year and revenue net of interest expense in the quarter topping market forecasts. See our latest analysis for International Bancshares. The latest earnings update lands after a solid run in the share price, with a 90 day share price return of 6.45% and a 1 year total shareholder return of 9.48%, building on a 5 year total shareholder return of 71.38%...